S564-0769 Screening compound: 4-[5-({1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl}methyl)-4H-1,2,4-triazol-3-yl]pyridine

S564-0769 Screening compound: 4-[5-({1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl}methyl)-4H-1,2,4-triazol-3-yl]pyridine
S564-0769 Screening compound: 4-[5-({1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl}methyl)-4H-1,2,4-triazol-3-yl]pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound S564-0769
4-[5-({1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl}methyl)-4H-1,2,4-triazol-3-yl]pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S564-0769

Molecular Formula

C24H27N5O2 (C24 H27 N5 O2)

Compound Name

4-[5-({1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl}methyl)-4H-1,2,4-triazol-3-yl]pyridine

IUPAC name

4-[5-({1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl}methyl)-4H-124-triazol-3-yl]pyridine

SMILES

COc1ccc(C2(CC2)C(N2CCC(Cc3nnc(-c4ccncc4)[nH]3)CC2)=O)cc1

InChI

InChI=1S/C24H27N5O2/c1-31-20-4-2-19(3-5-20)24(10-11-24)23(30)29-14-8-17(9-15-29)16-21-26-22(28-27-21)18-6-12-25-13-7-18/h2-7,12-13,17H,8-11,14-16H2,1H3,(H,26,27,28)

InChI Key

WZQXZCSFLQLGAT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31978841

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.812

Distribution Coefficient, logD

2.789

Water Solubility, LogSw

-3.00

Polar Surface Area

68.614

Acid Dissociation Constant (pKa)

4.47

Base Dissociation Constant (pKb)

4.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.67

S564-0769 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with S564-0769 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S564-0769?
Check Price and Availability of S564-0769, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S564-0769 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S564-0769
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S564-0769
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S564-0769 available by request